Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1993
11/25/1993WO1993023057A1 Method and reagent for inhibiting cancer development
11/25/1993WO1993023031A1 Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
11/25/1993WO1993023014A1 Chemotherapeutic drug combinations
11/25/1993WO1993023010A1 Ophthalmic compositions containing a cyclosporin
11/25/1993WO1993020203A3 Stability-enhanced variants of parathyroid hormone
11/25/1993WO1993020099A3 Cck and/or gastrin receptor ligands
11/25/1993WO1993019178A3 Peptides useful for inducing tolerance
11/25/1993WO1992019743A3 Hcv genomic sequences for diagnostics and therapeutics
11/25/1993DE4315921A1 Pharmaceutical prepn. contg. cyclosporin(s) for intravenous use
11/25/1993CA2136312A1 Retroviral protease inhibitors
11/25/1993CA2136091A1 Chemotherapeutic drug combinations
11/25/1993CA2135797A1 Brain transcription factors, nucleic acids encoding same and uses thereof
11/25/1993CA2135749A1 Platelet derived growth factor antagonists
11/25/1993CA2135748A1 Methods and agents for modulating immune response, and uses thereof
11/25/1993CA2135646A1 Method and reagent for inhibiting viral replication
11/25/1993CA2135499A1 Method and reagent for inhibiting cancer development
11/25/1993CA2135471A1 Receptor-type tyrosine kinase-like molecules
11/25/1993CA2135408A1 Chimeric multivalent protein analogues and methods of use thereof
11/25/1993CA2135390A1 Novel neutrophil inhibitors
11/25/1993CA2135306A1 Igf-1 analogs
11/25/1993CA2135201A1 Universal coronavirus vaccine
11/25/1993CA2134898A1 Compositions and methods for vaccination against coronaviruses
11/25/1993CA2118012A1 Hepatocyte growth factor variants
11/25/1993CA2112358A1 Use of igf-1
11/24/1993EP0570916A2 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
11/24/1993EP0570829A1 Pharmaceutical composition for intravenous administration containing cyclosporin and method for its preparation
11/24/1993EP0570791A2 Low caloric density enteral formulation designed to reduce diarrhoea in tube-fed patients
11/24/1993EP0570583A1 Hair modifier and hair care product, both containing antikeratinous antibody, and production of antikeratinous antibody
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods
11/24/1993EP0570507A1 Anti-aggregatory peptides containing an aromatic ester or amide
11/24/1993EP0570493A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING
11/24/1993EP0570478A1 Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response
11/24/1993EP0570462A1 MODIFIED INTERLEUKIN-1$g(b)
11/24/1993EP0570428A1 FACTOR IIa INHIBITORS
11/24/1993EP0570375A1 Novel peptides with anticoagulatory effect.
11/23/1993US5264577 Cyclic amino acids and derivatives thereof
11/23/1993US5264557 DNA segment for genes
11/23/1993US5264550 Human anti-inflammatory phospholipase inhibitor protein
11/23/1993US5264433 Benzodiazepine derivatives
11/23/1993US5264419 N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
11/23/1993US5264418 Immunoregulators with DNA
11/23/1993US5264416 Interleukin-7 receptors
11/23/1993US5264372 Receptor-based screening methods for amylin agonists and antagonists
11/23/1993US5264371 Screening method for neuroprotective compounds
11/23/1993US5264358 A mutated P53 gene incapable of expressing P53 proteins, a normal RB-1 gene, a normal C-FOS gene, ability to produce one or more growth factors
11/23/1993US5264357 Nucleic acids vectors and cells for the synthesis of membrane anchor fusion polypeptides
11/23/1993US5264216 Treatment of bacterial infections
11/23/1993US5264211 Administered in the form of aersol or by instillation; superoxide dismutase, respiratory disorder
11/23/1993US5264209 Modified HIL-6
11/23/1993US5264208 Potentiation of tumor necrosis factor (TNF) of interferon B1 (IFN-B1) antiviral activities by an anti-cachexia agent
11/23/1993CA1324527C Lipidic emulsion for parenteral or enteral use
11/21/1993CA2096576A1 7beta-substituted-4-aza-5alpha-cholestan-ones as 5alpha-reductase inhibitors
11/21/1993CA2096572A1 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
11/18/1993EP0570357A2 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
11/18/1993EP0570355A1 Use of prothrombin fragments
11/18/1993EP0570352A1 Novel hexapeptide
11/18/1993EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides
11/18/1993EP0569811A1 Dithiolanylglycine containing HIV-protease inhibitors of the hydroxyethylene isostere type
11/18/1993EP0569777A2 Methods for detecting beta amyloid precursor protein processing enzymes
11/18/1993EP0569703A2 Method of treating and preventing viral infections using HBNF and MK protein
11/18/1993EP0569687A1 Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
11/18/1993EP0569531A1 Stabilized antibody fragments
11/18/1993EP0569507A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy
11/18/1993EP0569487A1 Endothelin converting enzyme inhibitors
11/18/1993EP0569476A1 Repressors of the trans-activating function of papillomavirus e2 proteins
11/18/1993EP0569443A1 Novel peptide
11/18/1993EP0465481B1 New substituted alkylamide derivatives of teicoplanin
11/18/1993EP0362272B1 Method and compositions for making acsf and acsf antagonists
11/18/1993EP0332651B1 Method of isolating ca 125 antigen
11/18/1993EP0331743B1 Protein derived from living body
11/18/1993EP0327633B1 Procedure for relieving cell mixtures and tissues of unwanted populations
11/18/1993EP0313569B1 Enhancement of the cellular immune response
11/18/1993EP0171407B1 Improvements relating to growth factors
11/18/1993DE4216133A1 Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen Application of urodilatin in lung and bronchial
11/17/1993EP0641217A4 Amylase-electrolyte oral rehydration method and apparatus.
11/17/1993CN1078494A Protein compound, coding nucletide sequences, producing cell line and uses thereof
11/17/1993CN1078476A Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments
11/17/1993CN1078400A Method for reducing side effects of a drug
11/16/1993US5262528 Muceic acid encoding clone 19 gene product the gene product is the corresponing amino acid sequence
11/16/1993US5262524 Reaction with Fab fragments
11/16/1993US5262522 Receptor for oncostatin M and leukemia inhibitory factor
11/16/1993US5262521 Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
11/16/1993US5262520 Peptides and antibodies that inhibit integrin-ligand binding
11/16/1993US5262519 GRF analogs XI
11/16/1993US5262518 Infertility treatment, follicle stimulating hormone
11/16/1993US5262436 Acylamino acid antihypertensives in the treatment of congestive heart failure
11/16/1993US5262404 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
11/16/1993US5262325 Using heparinase free of anticoagulants
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993US5262309 Terminal modifications of tumor necrosis factor
11/16/1993US5262298 Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
11/16/1993US5262174 Administering lithnium salt with one of cytarabine or idoxyridine
11/16/1993US5262170 DNA sequences and proenzymes
11/16/1993US5262160 Insecticide active against mosquitoes and black flies
11/16/1993US5262152 Amidrazones and derivatives thereof
11/16/1993CA2096076A1 Use of prothrombin fragments
11/16/1993CA1324378C Perhydroazacycloalka [1,2-a] imidazole derivatives and use thereof as nootropic agents
11/16/1993CA1324331C Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
11/15/1993CA2095968A1 Dithiolanylglycine-containing hiv protease inhibitors of the hydroxyethylene isostere type
1 ... 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 ... 3163